Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Studies on tumor induced angiogenesis.

J L Ambrus1, C M Ambrus, C A Toumbis

  • 1Roswell Park Cancer Institute, Buffalo, NY 14263.

Journal of Medicine
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxicity of penicillin and aureomycin in guinea pigs.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Effect of broad spectrum antibiotics on tumor inducing viruses.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same authorSame journal

Multiple medical problems following agent orange exposure.

Journal of medicine·2007
Same author

Myocardial release of non-transferrin-bound iron during cardio-pulmonary bypass surgery.

Journal of medicine·2007
Same author

Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine.

Journal of medicine·2007
Same author

Therapy of newly emerging mutant viral disorders and role in bioterrorism.

Medical hypotheses·2005

Researchers investigated angiogenesis, the formation of new blood vessels, in response to tumor growth. They found that platelet-derived growth factor (PDGF) promotes angiogenesis, while certain hemorheologic and anti-fibrinolytic agents inhibit it.

Area of Science:

  • Ophthalmology
  • Oncology
  • Pharmacology

Background:

  • Angiogenesis is crucial for tumor growth and metastasis.
  • Understanding factors that promote or inhibit angiogenesis is vital for cancer treatment.

Purpose of the Study:

  • To evaluate the angiogenic potential of human tumor implants and biologic agents in vivo.
  • To identify agents that can inhibit tumor-induced angiogenesis.

Main Methods:

  • Developed methods to assess angiogenic response in rabbit and non-human primate corneas.
  • Utilized human malignant melanoma implants and various growth factors and inhibitors.

Main Results:

  • Human tumor implants and platelet-derived growth factor (PDGF) induced significant angiogenesis.

Related Experiment Videos

  • Pentoxifylline (Px) and sodium diethyldithiocarbamate (DDTC) inhibited tumor-induced angiogenesis.
  • Anti-fibrinolytic agents epsilon amino caproic acid (EACA) and tranexamic acid (t-AMCHA) demonstrated anti-angiogenic properties.

    • Conclusions:

    • PDGF is a potent initiator of angiogenesis.
    • Hemorheologic agents like pentoxifylline and agents like DDTC show promise in inhibiting tumor angiogenesis.
    • Anti-fibrinolytic agents also possess anti-angiogenic activity, suggesting potential therapeutic applications.